Skip to main content
. Author manuscript; available in PMC: 2020 Jul 31.
Published in final edited form as: Crit Rev Toxicol. 2018 Feb 23;48(5):359–374. doi: 10.1080/10408444.2018.1429386

Table 5.

Defined Approach (DA) performance in predicting human sensitizing potency.

Predicting Human Potency (Strong, Weak, Non-sensitizers)
Defined Approach: Kao
STS
Kao
ITS
Shiseido ANN
(D_hC)
Shiseido
ANN
(D_hC_KS)
P&G
BN ITS-3
LLNA
N 126 120 126 126 115 128
Accuracy (%)* 63.5 69.2 61.1 62.7 54.8 59.4
Over-predicted (%) 22.2 13.3 22.2 25.4 20.0 19.5
Under-predicted (%) 14.3 17.5 16.7 11.9 25.2 21.1
*

Performance was assessed for prediction of three potency classes as described in the main text, and is shown against the maximum subset (N) out of 128 substances with all necessary DA features. With the exception of the P&G BN ITS-3, all misclassifications varied by one class only (i.e. no non-sensitizers were predicted as strong sensitizers or vice versa). Abbreviations: STS: sequential testing strategy, ITS: integrated testing strategy, SVM: support vector machine, ANN: artificial neural network, BN: Bayesian network, DKH and D_hC_KS: DPRA/hCLAT/KeratinoSens™, D_hC: DPRA/hCLAT